NASDAQ
Ionis Pharmaceuticals, Inc. (IONS) has a free cash flow growth of -412.31% as of Friday, May 29, 2026. This represents a 3355.50% decrease compared to its 12-month average of -11.93%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.